Related references
Note: Only part of the references are listed.Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up
Urs E. Studer et al.
EUROPEAN UROLOGY (2014)
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy
M. T. Schweizer et al.
ANNALS OF ONCOLOGY (2013)
Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
Patrick Berkovic et al.
CLINICAL GENITOURINARY CANCER (2013)
Stereotactic body radiotherapy for oligometastases
Alison C. Tree et al.
LANCET ONCOLOGY (2013)
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model
S. Salah et al.
ANNALS OF ONCOLOGY (2012)
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
Emmanuel S. Antonarakis et al.
BJU INTERNATIONAL (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review
L. Spelt et al.
EJSO (2012)
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database
Emmanuel S. Antonarakis et al.
BJU INTERNATIONAL (2011)
High-Dose Salvage Intensity-Modulated Radiotherapy With or Without Androgen Deprivation After Radical Prostatectomy for Rising or Persisting Prostate-Specific Antigen: 5-Year Results
Piet Ost et al.
EUROPEAN UROLOGY (2011)
Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
Stephen A. Boorjian et al.
EUROPEAN UROLOGY (2011)
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
Maria Picchio et al.
EUROPEAN UROLOGY (2011)
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
Patrizio Rigatti et al.
EUROPEAN UROLOGY (2011)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Nicolas Mottet et al.
EUROPEAN UROLOGY (2011)
MicroRNA Expression Characterizes Oligometastasis(es)
Yves A. Lussier et al.
PLOS ONE (2011)
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
Per-Anders Abrahamsson
EUROPEAN UROLOGY (2010)
The Number of Pulmonary Metastases Influence on Practice and Outcome
Mariano Garcia-Yuste et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
The COMPARE Registry: Design and Baseline Patterns of Care for Men With Biochemical Failure After Definitive Treatment of Localized Prostate Cancer
Oliver Sartor et al.
UROLOGY (2010)
Review of Major Adverse Effects of Androgen-deprivation Therapy in Men With Prostate Cancer
Lockwood G. Taylor et al.
CANCER (2009)
Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion
Valerie Fonteyne et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy
Danil V. Makarov et al.
JOURNAL OF UROLOGY (2008)
Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: A matched cohort study
Sameer A. Siddiqui et al.
JOURNAL OF UROLOGY (2008)
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline
D. Andrew Loblaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The natural history of noncastrate metastatic prostate cancer after radical prostatectomy
Ofer Yossepowitch et al.
EUROPEAN UROLOGY (2007)
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy
JW Moul et al.
JOURNAL OF UROLOGY (2004)
Is there a favorable subset of patients with prostate cancer who develop oligometastases?
D Singh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Share Paper
